This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...
Workplace stress, long hours, and unhealthy habits are raising diabetes risk among India’s young professionals. Awareness and ...
Novo Nordisk A/S remains attractive with strong cash flow and robust pipeline. Click here to read why NVO stock is a Buy.
The Hearty Soul on MSN
An Apple a Day? 5 Benefits of Apples From Gut Health to Weight Loss
An apple a day keeps the doctor away, or so the old proverb says. But, is there any truth to it? Apples are both affordable ...
Modern Family Driver on MSN
Ozempic’s Shocking Impact on Obesity Rates Is Finally Here
GLP-1 drugs like Ozempic are reshaping obesity care, blending real weight loss gains with new questions about safety, access, ...
In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Colleen Dawkins, FNP-C, RD, CSOWM ...
JD Vance has revealed Donald Trump’s extreme nocturnal demands for White House staff traveling with him. The vice president, ...
Sanofi's Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes Recommendation based on the TN-10 study, demonstrating Teizeild's ability to delay the onset of stag ...
The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback